May 26, 2020 8:33am

Regenerative Medicine Earnings listing for Q1/20  

My focus is to define the net income or loss, the per share amounts commonly an LPS (loss-per-share), cash positions (EOQ – “end-of-quarter”) and the “runway” of continuing operations.


Schedule for the LPS (loss-per-share) earnings of Q1/2020 of my 35 covered companies:


Coming this week on 5/28:

Adverum Biotechnologies (ADVM)

Mesoblast (MESO)